Franklin Resources
SUPN icon

Franklin Resources’s Supernus Pharmaceuticals SUPN Stock Holding History

Franklin Resources’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Sell
85,289
-667
-0.8% -$32K ﹤0.01% 1726
2026
Q1 		$4.44M Sell
85,956
-5,062
-6% -$258K ﹤0.01% 1574
2025
Q4 		$4.52M Sell
91,018
-4,365
-5% -$212K ﹤0.01% 1442
2025
Q3 		$4.56M Buy
95,383
+55,528
+139% +$2.24M ﹤0.01% 1451
2025
Q2 		$1.26M Buy
39,855
+1,897
+5% +$60.8K ﹤0.01% 1901
2025
Q1 		$1.24M Buy
37,958
+6,350
+20% +$225K ﹤0.01% 1868
2024
Q4 		$1.14M Buy
31,608
+1,627
+5% +$57.3K ﹤0.01% 1930
2024
Q3 		$987K Buy
29,981
+2,121
+8% +$66.2K ﹤0.01% 1989
2024
Q2 		$745K Buy
27,860
+3,217
+13% +$93.2K ﹤0.01% 2058
2024
Q1 		$841K Sell
24,643
-1,073
-4% -$31.9K ﹤0.01% 2021
2023
Q4 		$744K Sell
25,716
-3,102
-11% -$82.2K ﹤0.01% 1770
2023
Q3 		$795K Sell
28,818
-387
-1% -$11.8K ﹤0.01% 1701
2023
Q2 		$878K Buy
29,205
+23,624
+423% +$827K ﹤0.01% 1693
2023
Q1 		$202K Buy
+5,581
New +$215K ﹤0.01% 1999

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Franklin Resources's SUPN Position: Q2 2026 in Review

Franklin Resources reduced its Supernus Pharmaceuticals (SUPN) stake by 0.78% in Q2 2026, selling an estimated $32K and leaving 85,289 shares worth $3.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1726.

Franklin Resources first reported a position in SUPN in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.56M in Q3 2025. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Franklin Resources held 85,289 shares of Supernus Pharmaceuticals worth $3.97M as of Q2 2026.
  • Franklin Resources sold 667 Supernus Pharmaceuticals shares in Q2 2026, an estimated $32K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1726 holding.
  • Franklin Resources first reported a position in Supernus Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Franklin Resources's Supernus Pharmaceuticals position peaked at $4.56M in Q3 2025.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.